Patients and other stakeholders now have an opportunity to fully understand the extent of the research-based industry's concerns regarding the proposals in the Health Technology Assessment Review options paper, with Medicines Australia releasing its response. …
Stakeholders can now see what the industry really thinks about HTA review options
March 8, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
BCAL advances early cancer detection portfolio as Australian launch looms
November 19, 2025 - - Australian Biotech -
Minister managing the 'double-whammy' of participant and plan growth
November 19, 2025 - - Latest News -
Is this disconnect so entrenched we can no longer recognise the presence of a problem?
November 19, 2025 - - Latest News -
Tryp advances psilocin trial for binge eating disorder as second patient enrolled
November 18, 2025 - - Australian Biotech -
Nyrada advances toward Phase 2a trial of cardioprotective candidate
November 18, 2025 - - Australian Biotech -
We know they're planning something on these issues, because they told us
November 18, 2025 - - Latest News -
The need to honour a strong history while ensuring the future is guided by the 'good guys'
November 17, 2025 - - Latest News